148 related articles for article (PubMed ID: 38574300)
1. Lung Cancer Clinical Trials in Latin America in the Era of Cooperative Groups: A 20-Year Analysis.
Knapp T; Nygaard J; Cassinat J; Galvez F; Gopalan PK
JCO Glob Oncol; 2024 Apr; 10():e2300379. PubMed ID: 38574300
[TBL] [Abstract][Full Text] [Related]
2. Updated Frequency of EGFR and KRAS Mutations in NonSmall-Cell Lung Cancer in Latin America: The Latin-American Consortium for the Investigation of Lung Cancer (CLICaP).
Arrieta O; Cardona AF; Martín C; Más-López L; Corrales-Rodríguez L; Bramuglia G; Castillo-Fernandez O; Meyerson M; Amieva-Rivera E; Campos-Parra AD; Carranza H; Gómez de la Torre JC; Powazniak Y; Aldaco-Sarvide F; Vargas C; Trigo M; Magallanes-Maciel M; Otero J; Sánchez-Reyes R; Cuello M
J Thorac Oncol; 2015 May; 10(5):838-843. PubMed ID: 25634006
[TBL] [Abstract][Full Text] [Related]
3. [Toward a model of communications in public health in Latin America and the Caribbean].
Macías-Chapula CA
Rev Panam Salud Publica; 2005 Dec; 18(6):427-38. PubMed ID: 16536929
[TBL] [Abstract][Full Text] [Related]
4. Potential negative impact of reputed regulators' decisions on the approval status of new cancer drugs in Latin American countries: A descriptive analysis.
Durán CE; Cañás M; Urtasun M; Elseviers M; Vander Stichele R; Christiaens T
PLoS One; 2021; 16(7):e0254585. PubMed ID: 34255795
[TBL] [Abstract][Full Text] [Related]
5. [Financial impact of smoking on health systems in Latin America: A study of seven countries and extrapolation to the regional level].
Pichon-Riviere A; Bardach A; Augustovski F; Alcaraz A; Reynales-Shigematsu LM; Pinto MT; Castillo-Riquelme M; Torres EP; Osorio DI; Huayanay L; Munarriz CL; de Miera-Juárez BS; Gallegos-Rivero V; Puente C; Navia-Bueno MD; Caporale J
Rev Panam Salud Publica; 2016 Oct; 40(4):213-221. PubMed ID: 28001196
[TBL] [Abstract][Full Text] [Related]
6. Seminar on adult mortality and orphanhood in the past: five Latin American cases.
Rabell C; Necochea N; Arretx C; Salinas R; Ferrando D; Ponce F; Burmester AM; De Macedo IS; Nadalin SO
Newsl Int Union Sci Study Popul; 1986; (28):19-44. PubMed ID: 12179538
[TBL] [Abstract][Full Text] [Related]
7. Genotyping non-small cell lung cancer (NSCLC) in Latin America.
Arrieta O; Cardona AF; Federico Bramuglia G; Gallo A; Campos-Parra AD; Serrano S; Castro M; Avilés A; Amorin E; Kirchuk R; Cuello M; Borbolla J; Riemersma O; Becerra H; Rosell R;
J Thorac Oncol; 2011 Nov; 6(11):1955-9. PubMed ID: 22005474
[TBL] [Abstract][Full Text] [Related]
8. Distribution and trends of hematology and oncology research in Latin America: A decade of uncertainty.
Acevedo AM; Gómez A; Becerra HA; Ríos AP; Zambrano PC; Obando EP; Martí-Carvajal AJ; Carranza H; Vargas CA; Otero JM; Reveiz L; Cardona AF
Cancer; 2014 Apr; 120(8):1237-45. PubMed ID: 24382827
[TBL] [Abstract][Full Text] [Related]
9. The burden of skeletal-related events in four Latin American countries: Argentina, Brazil, Colombia, and Mexico.
Garcia Perlaza J; Aziziyeh R; Zhou A; De Sousa Barbosa V; Amaya J; Caporale J; Alva ME; Forero J; Tanaka S; Suri G; Garcia D
J Med Econ; 2021; 24(1):983-992. PubMed ID: 34325606
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008-2010).
Gales AC; Castanheira M; Jones RN; Sader HS
Diagn Microbiol Infect Dis; 2012 Aug; 73(4):354-60. PubMed ID: 22656912
[TBL] [Abstract][Full Text] [Related]
11. What predicts the quality of advanced cancer care in Latin America? A look at five countries: Argentina, Brazil, Cuba, Mexico, and Peru.
Torres Vigil I; Aday LA; De Lima L; Cleeland CS
J Pain Symptom Manage; 2007 Sep; 34(3):315-27. PubMed ID: 17616337
[TBL] [Abstract][Full Text] [Related]
12. Contribution of Latin American Countries to Cancer Research and Patent Generation: Recent Patents.
Perez-Santos M; Anaya-Ruiz M; Bandala C
Recent Pat Anticancer Drug Discov; 2017; 12(1):81-93. PubMed ID: 27739356
[TBL] [Abstract][Full Text] [Related]
13. Association of moderate-to-vigorous physical activity with neck circumference in eight Latin American countries.
Luis de Moraes Ferrari G; Kovalskys I; Fisberg M; Gomez G; Rigotti A; Sanabria LYC; García MCY; Torres RGP; Herrera-Cuenca M; Zimberg IZ; Guajardo V; Pratt M; Pires C; Solé D;
BMC Public Health; 2019 Jun; 19(1):809. PubMed ID: 31234866
[TBL] [Abstract][Full Text] [Related]
14. A random sample survey of initial drug resistance among tuberculosis cases in Latin America.
Laszlo A; de Kantor IN
Bull World Health Organ; 1994; 72(4):603-10. PubMed ID: 7923539
[TBL] [Abstract][Full Text] [Related]
15. Adolescent Tobacco Exposure in 31 Latin American Cities before and after the Framework Convention for Tobacco Control.
Prado-Galbarro FJ; Auchincloss AH; Pérez-Ferrer C; Sanchez-Franco S; Barrientos-Gutierrez T
Int J Environ Res Public Health; 2020 Oct; 17(20):. PubMed ID: 33053821
[TBL] [Abstract][Full Text] [Related]
16. How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be?
Han R; Gomez JA; de Veras B; Pinto T; Guzman-Holst A; Nieto J; van Oorschot DAM
Hum Vaccin Immunother; 2023 Dec; 19(1):2164144. PubMed ID: 36821856
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 blues: Lockdowns and mental health-related google searches in Latin America.
Silverio-Murillo A; Hoehn-Velasco L; Rodriguez Tirado A; Balmori de la Miyar JR
Soc Sci Med; 2021 Jul; 281():114040. PubMed ID: 34144481
[TBL] [Abstract][Full Text] [Related]
18. Health care providers' assessments of the quality of advanced-cancer care in Latin American medical institutions: a comparison of predictors in five countries: Argentina, Brazil, Cuba, Mexico, and Peru.
Torres-Vigil I; Aday LA; Reyes-Gibby C; De Lima L; Herrera AP; Mendoza T; Cleeland CS
J Pain Palliat Care Pharmacother; 2008; 22(1):7-20. PubMed ID: 19042817
[TBL] [Abstract][Full Text] [Related]
19. Optimizing Tobacco Advertising Bans in Seven Latin American Countries: Microsimulation Modeling of Health and Financial Impact to Inform Evidence-Based Policy.
Bardach A; Alcaraz A; Roberti J; Ciapponi A; Augustovski F; Pichon-Riviere A
Int J Environ Res Public Health; 2021 May; 18(10):. PubMed ID: 34064880
[TBL] [Abstract][Full Text] [Related]
20. Impact Assessment of Divergence on Post-approval Changes Classifications of Latin America Region With Europe and the United States, and Propositions to Harmonize Classification Based on Risk as a Path to Build the Trust Between National Regulatory Agencies.
De Lucia ML; Comesaña C; Rodriguez H; Dangy-Caye A
Clin Ther; 2024 Feb; 46(2):164-172. PubMed ID: 38092583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
